L & S Advisors Inc Regeneron Pharmaceuticals, Inc. Transaction History

L & S Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $3.3 Million - $4.19 Million	-6,894 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $111,129 - $134,274	-204 Reduced 2.87%	6,894 $3.86 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $3.5 Million - $4.57 Million	7,098 New	7,098 $4.43 Million
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $591,215 - $737,156	-1,872 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $76,029 - $99,629	212 Added 12.77%	1,872 $704,000
Q3 2017 Nov 14, 2017	SELL	$431.38 - $504.0 $69,020 - $80,640	-160 Reduced 8.79%	1,660 $742,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,820	1,820 $894,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on L & S Advisors Inc with notifications on news.